Your browser doesn't support javascript.
loading
Continuous Renal Replacement Therapy for a Patient with Severe COVID-19.
Katagiri, Daisuke; Ishikane, Masahiro; Ogawa, Tatsunori; Kinoshita, Noriko; Katano, Harutaka; Suzuki, Tadaki; Fukaya, Takashi; Hinoshita, Fumihiko; Ohmagari, Norio.
Affiliation
  • Katagiri D; Department of Nephrology, National Center for Global Health and Medicine, Tokyo, Japan, dkatagiri@hosp.ncgm.go.jp.
  • Ishikane M; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Ogawa T; Medical Equipment Management Office, National Center for Global Health and Medicine, Tokyo, Japan.
  • Kinoshita N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Katano H; Department of Pathology, National Institute of Infectious Disease, Tokyo, Japan.
  • Suzuki T; Department of Pathology, National Institute of Infectious Disease, Tokyo, Japan.
  • Fukaya T; Medical Equipment Management Office, National Center for Global Health and Medicine, Tokyo, Japan.
  • Hinoshita F; Department of Nephrology, National Center for Global Health and Medicine, Tokyo, Japan.
  • Ohmagari N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Blood Purif ; 50(1): 129-131, 2021.
Article in En | MEDLINE | ID: mdl-32526746

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acute Kidney Injury / Continuous Renal Replacement Therapy / COVID-19 Limits: Humans / Male Language: En Journal: Blood Purif Year: 2021 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acute Kidney Injury / Continuous Renal Replacement Therapy / COVID-19 Limits: Humans / Male Language: En Journal: Blood Purif Year: 2021 Type: Article